Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia
Conclusion: CLAG was effective and well tolerated for R/R AML. BM blasts ≥42.1%, age ≥60 years, high risk stratification, and second or higher salvage therapy were independent factors for a poor prognosis.Acta Haematol 2019;141:43 –53
Source: Acta Haematologica - Category: Hematology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Anemia | China Health | Filgrastim | Leukemia | Neulasta | Neupogen | Study | Thrombocytopenia